OR

Browse By

A Randomised Phase II Trial of Adjuvant Avelumab in Patients with Early Stage Merkel Cell Carcinoma (2019–2025)

Grant type:
NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
Funded by:
Commonwealth Department of Health and Aged Care